Review continued need/effectiveness after 3 to 6 months
CAUTION: Anticholinergic ADRs (oxybutynin may decrease MMSE score in people with dementia)
test announcement
Review continued need/effectiveness after 3 to 6 months
CAUTION: Anticholinergic ADRs (oxybutynin may decrease MMSE score in people with dementia)